Approval · Notice of Compliance 31701 · 2023
EVKEEZA: Notice of Compliance 31701
Issued September 22, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31701
- Date
- September 22, 2023
- Company
- Ultragenyx Pharmaceutical IncNovato, California, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVKEEZA | 02541769 | Marketed |
Medicinal ingredients
- EVINACUMAB 150 MG per ML